GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » EV-to-Revenue

Proteomics International Laboratories (ASX:PIQ) EV-to-Revenue : 228.08 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Proteomics International Laboratories's enterprise value is A$132.51 Mil. Proteomics International Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.58 Mil. Therefore, Proteomics International Laboratories's EV-to-Revenue for today is 228.08.

The historical rank and industry rank for Proteomics International Laboratories's EV-to-Revenue or its related term are showing as below:

ASX:PIQ' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.79   Med: 17.69   Max: 192.76
Current: 228.09

During the past 9 years, the highest EV-to-Revenue of Proteomics International Laboratories was 192.76. The lowest was 4.79. And the median was 17.69.

ASX:PIQ's EV-to-Revenue is ranked worse than
89.31% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs ASX:PIQ: 228.09

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Proteomics International Laboratories's stock price is A$1.05. Proteomics International Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01. Therefore, Proteomics International Laboratories's PS Ratio for today is 210.00.


Proteomics International Laboratories EV-to-Revenue Historical Data

The historical data trend for Proteomics International Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories EV-to-Revenue Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 18.32 25.71 70.01 64.60 134.28

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 64.60 - 134.28 -

Competitive Comparison of Proteomics International Laboratories's EV-to-Revenue

For the Biotechnology subindustry, Proteomics International Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteomics International Laboratories's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's EV-to-Revenue falls into.



Proteomics International Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Proteomics International Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=132.514/0.581
=228.08

Proteomics International Laboratories's current Enterprise Value is A$132.51 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteomics International Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteomics International Laboratories  (ASX:PIQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Proteomics International Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.05/0.005
=210.00

Proteomics International Laboratories's share price for today is A$1.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteomics International Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteomics International Laboratories (ASX:PIQ) Business Description

Traded in Other Exchanges
N/A
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines